EBC

The Foundation for Business Equity (FBE) and Eastern Bank Announce the Merger of FBE with Mill Cities Community Investments

Retrieved on: 
Mittwoch, Dezember 7, 2022
Professional Services, Philanthropy, Small Business, Finance, Foundation, Banking, Small business, Housing, Lawrence, Massachusetts, Ecosystem, Partnership, EBC, Bank, The Boston Foundation, Knowledge, Federal Reserve Bank, CDFI, BEI, BEF, Investment, MA, Growth, Federal Reserve Bank of St. Louis, MCCI, FBE, Organization, Airline, Financial services, Eastern Bank, Merrimack Valley

Eastern Bank and the Foundation for Business Equity (FBE), an award-winning Boston-based nonprofit organization working to scale small businesses of color, are pleased to announce the merger of FBE with Mill Cities Community Investments (MCCI), a significant step to strengthening their services and extending their impact.

Key Points: 
  • Eastern Bank and the Foundation for Business Equity (FBE), an award-winning Boston-based nonprofit organization working to scale small businesses of color, are pleased to announce the merger of FBE with Mill Cities Community Investments (MCCI), a significant step to strengthening their services and extending their impact.
  • The merger marks a major milestone in the continued growth of FBE and the completion of its incubation period at Eastern Bank.
  • The Eastern Bank Foundation is proud to have incubated the Foundation for Business Equity and help it to reach this next stage of growth with the MCCI team.
  • Created in 1994, the Eastern Bank Foundation is the philanthropic arm of Boston-based Eastern Bank.

Lilly Announces Updated Data from the Verzenio® (abemaciclib) Phase 3 monarchE Trial Presented at SABCS and Simultaneously Published in The Lancet Oncology

Retrieved on: 
Dienstag, Dezember 6, 2022
The Lancet, Monarch butterfly migration, Recurrence, Cohort, Eli Lilly and Company, EBC, Ki-67, Patient, ET, Royal Marsden Hospital, NYSE, Breast cancer, Disease, Breast cancer classification, ALN, NHS foundation trust, Woman, Nominal interest rate, Death, ITT, The Royal Marsden NHS Foundation Trust, Risk, Pharmaceutical industry, Abemaciclib

INDIANAPOLIS, Dec. 6, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced updated results from the pivotal Phase 3 monarchE trial of adjuvant Verzenio® (abemaciclib) in combination with standard endocrine therapy (ET) for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), node-positive, high risk early breast cancer (EBC). These data, which include results for investigational uses in the intent-to-treat (ITT) and Cohort 1 populations, were presented today as an oral presentation at the 2022 San Antonio Breast Cancer Symposium (SABCS) and simultaneously published in The Lancet Oncology.

Key Points: 
  • The monarchE trial (N=5,637) included women and men with HR+, HER2-, node-positive EBC with a high risk of disease recurrence.
  • Adjuvant Verzenio also reduced the risk of developing metastatic disease by 34.1% (HR=0.659, 95% CI: 0.567, 0.767; nominal p
  • Data presented at SABCS also included efficacy outcomes in the FDA-approved population, as well as the Cohort 1 population.
  • Nearly twice as many patients in the control arm have developed and are living with metastatic disease compared to those receiving Verzenio.

Lilly Announces Details of Presentations at 2022 San Antonio Breast Cancer Symposium

Retrieved on: 
Montag, November 21, 2022
The Monarch School, Adult, Cell death, Food and Drug Administration, PI3K, Growth, Cancer, EMBER, Cyclin D1, Recurrence, Plasma, Breast, Febrile neutropenia, PIK3CA, Rb, Woman, Cell proliferation, Diarrhea, SERD, Infection, ER, Tamoxifen, Traffic barrier, CDK, Physician, Cerebrospinal fluid, Eli Lilly and Company, FDA, Breast cancer, Breast cancer classification, Phosphorylation, ESR1, ET, EBC, NYSE, OS, S phase, Hospital, Pharmacology, Patient, Molecular biology, Grade 3, Apoptosis, Toxicity, Risk, Dehydration, Cyclin-dependent kinase, Loperamide, Lilly, Retinoblastoma protein, Food, Cell cycle, Preclinical development, Grade 2, Pharmaceutical industry, Birth control, Medical imaging, Abemaciclib, Neutropenia, G1

INDIANAPOLIS, Nov. 21, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY)today announced that study investigators will present data from its breast cancer portfolio and pipeline at the 2022 San Antonio Breast Cancer Symposium (SABCS), to be held December 6-10, 2022, in San Antonio, Texas, and virtually.

Key Points: 
  • INDIANAPOLIS, Nov. 21, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY)today announced that study investigators will present data from its breast cancer portfolio and pipeline at the 2022 San Antonio Breast Cancer Symposium (SABCS), to be held December 6-10, 2022, in San Antonio, Texas, and virtually.
  • In addition, pharmacodynamic data from the preoperative EMBER-2 trial evaluating imlunestrant in ER+, HER2- early breast cancer will be provided.
  • Preclinical data with LOXO-783 in combination with standard-of-care breast cancer agents will also be presented at the meeting.
  • In patients with advanced cancer, including breast cancer, concentrations of Verzenio and its active metabolites (M2 and M20) in cerebrospinal fluid are comparable to unbound plasma concentrations.

Ritz Momentum Releases Tips Advising Amazon Sellers on How to Start an Amazon FBA Business

Retrieved on: 
Montag, November 14, 2022
Momentum, DTC, EBC, Marketing, Research, Multimedia, PPC, Create, FBA, CEO, View, Online shopping, Food delivery, Amazon

ORLANDO, Fla., Nov. 14, 2022 /PRNewswire/ -- In its continuous efforts to help Amazon sellers, Ritz Momentum has recently come up with a series of useful business tips. These detailed guidelines have been shared to make life easier for aspiring businessmen looking to figure out how to start an Amazon business. Founded in 2019, the company offers a plethora of services including Amazon product research, Amazon listing picture creation, Amazon pay-per-click and account management, Amazon listing copywriting, Amazon listing optimization, EBC content design, and much more. 

Key Points: 
  • Popular one-stop-shop for Amazon business services, Ritz Momentum recently discussed how to start an Amazon business.
  • ORLANDO, Fla., Nov. 14, 2022 /PRNewswire/ -- In its continuous efforts to help Amazon sellers, Ritz Momentum has recently come up with a series of useful business tips.
  • Fulfillment by Amazon (FBA) is a service where the shipping and logistics are handled by Amazon, and Amazon sellers are free to manage the business and sell their products.
  • Ritz Momentum informs that the very first step for starting an Amazon FBA business is to set up an Amazon seller account.

Ritz Momentum Helps Amazon FBA Sellers Make Data-Informed Decisions in Product Design

Retrieved on: 
Freitag, November 11, 2022
Momentum, EBC, Exploration, PPC, DTC, Multimedia, View, FBA, Time, Data, Online shopping, Sales, Amazon

ORLANDO, Fla., Nov. 11, 2022 /PRNewswire/ -- Ritz Momentum, an agency dedicated to providing end-to-end business solutions to Amazon FBA business owners, continues to expand its service. The company is now receiving accolades by helping Amazon sellers with their product design. Ritz Momentum utilizes data to create and validate product ideas, protecting Amazon online store owners from all types of product development risks.

Key Points: 
  • Noted provider of Amazon business solutions, Ritz Momentum is now providing advanced product design support to Amazon FBA sellers with a data-centric approach.
  • The company is now receiving accolades by helping Amazon sellers with their product design.
  • Ritz Momentum utilizes data to create and validate product ideas, protecting Amazon online store owners from all types of product development risks.
  • To find out more about Ritz Momentum and its service capabilities, please visit https://www.ritzarm.com/
    Ritz Momentum's Amazon FBA product design process works in two steps.

Eastern Bank and Eastern Insurance Group LLC Welcome The Forsyth Institute As A New Customer

Retrieved on: 
Mittwoch, November 2, 2022
Banking, Professional Services, Finance, Growth, Nasdaq, The Forsyth Institute, CEO, Acquisition, Forsyth, Dentistry, EBC, Research, National FongShan Senior Commercial & Industrial Vocational School, Bank, Multimedia, Solution, Insurance, Management, Eastern Bank

Eastern Bank and Eastern Insurance Group LLC , a wholly owned subsidiary of Eastern Bank, are pleased to announce The Forsyth Institute (Forsyth) as a new commercial banking and insurance customer.

Key Points: 
  • Eastern Bank and Eastern Insurance Group LLC , a wholly owned subsidiary of Eastern Bank, are pleased to announce The Forsyth Institute (Forsyth) as a new commercial banking and insurance customer.
  • In addition, Eastern Insurance Group has consulted with Forsyth to develop a customized risk management program for Forsyths commercial, personal and employee benefits needs.
  • View the full release here: https://www.businesswire.com/news/home/20221102005665/en/
    The Forsyth Institute is thrilled to begin new relationships with Eastern Bank and Eastern Insurance Group, said Dr. Wenyuan Shi, Chief Executive Officer and Chief Scientific Officer of The Forsyth Institute.
  • Eastern provides banking, investment and insurance products and services for consumers and businesses of all sizes, including through its Eastern Wealth Management division and its Eastern Insurance Group LLC subsidiary.

Eastern Bank Welcomes Crime Prevention Security Systems, LLC As A Commercial Customer

Retrieved on: 
Mittwoch, Oktober 12, 2022
Professional Services, Public Policy, Government, Law Enforcement, Emergency Services, Security, Technology, Finance, Banking, LinkedIn, National FongShan Senior Commercial & Industrial Vocational School, Security alarm, LLC, Bank, Twitter, Instagram, Senior, EBC, Acquisition, Nasdaq, Commercial bank, CPSS, Central Florida, Eastern Bank, Facebook

Eastern Bank is pleased to announce Crime Prevention Security Systems, LLC (CPSS) as a new commercial customer.

Key Points: 
  • Eastern Bank is pleased to announce Crime Prevention Security Systems, LLC (CPSS) as a new commercial customer.
  • Crime Prevention Security Systems is thrilled to begin a new banking relationship with Eastern Bank, said John Pastore, Founder and President of Crime Prevention Security Systems, LLC.
  • For over 45 years, Crime Prevention Security Systems has been recognized as a local leader in security and alarm products, providing peace of mind and excellent customer service to their customers, said Greg Buscone, Executive Vice President, Senior Commercial Banking Officer of Eastern Bank.
  • The Commercial Banking team advising Crime Prevention Security Systems includes Executive Vice President, Senior Commercial Banking Officer Greg Buscone and Senior Vice President, Commercial Group Director Brendan ONeill.

Eastern Bankshares, Inc. Announces Third Quarter 2022 Earnings Release Date, Conference Call and Webcast

Retrieved on: 
Dienstag, Oktober 4, 2022
Banking, Professional Services, Finance, Webcast, Corus Bankshares, Nasdaq, EBC, Eastern Bank

Eastern Bankshares, Inc. (the Company) (Nasdaq Global Select Market: EBC), a Massachusetts corporation and the stock holding company for Eastern Bank, today announced the following details regarding the report of the Companys third quarter 2022 results:

Key Points: 
  • Eastern Bankshares, Inc. (the Company) (Nasdaq Global Select Market: EBC), a Massachusetts corporation and the stock holding company for Eastern Bank, today announced the following details regarding the report of the Companys third quarter 2022 results:
    The conference call will be simultaneously webcast.
  • Eastern Bankshares, Inc. is the stock holding company for Eastern Bank.
  • Founded in 1818, Boston-based Eastern Bank has more than 120 locations serving communities in eastern Massachusetts, southern and coastal New Hampshire, and Rhode Island.
  • As of June 30, 2022, Eastern Bank had approximately $22 billion in total assets.

Lilly Announces Details of Presentations at ESMO Congress 2022

Retrieved on: 
Mittwoch, September 7, 2022
Patient, Breast cancer, Cyclin D1, Cell cycle, Technology, Food and Drug Administration, Preclinical development, S phase, Man, Recurrence, RET, Rb, EBC, Food, Transfection, CDK, Traffic barrier, Lilly, Tamoxifen, Plasma, FDA, Phosphorylation, Breast cancer classification, Adult, ET, Cell death, Cell proliferation, Cerebrospinal fluid, Woman, Growth, Apoptosis, Cyclin-dependent kinase, Retinoblastoma protein, Pharmaceutical industry, Medical imaging, Abemaciclib, G1

A Grade 3 decrease in neutrophil count (based on laboratory findings) occurred in 19 to 32% of patients receiving Verzenio.

Key Points: 
  • A Grade 3 decrease in neutrophil count (based on laboratory findings) occurred in 19 to 32% of patients receiving Verzenio.
  • Lilly unites caring with discovery to create medicines that make life better for people around the world.
  • P-LLY
    Verzenio and Retevmo are trademarks owned by or licensed toEli Lilly and Company, its subsidiaries, or affiliates.
  • Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.

Eastern Bankshares, Inc. Announces New Share Repurchase Program

Retrieved on: 
Mittwoch, September 7, 2022
Banking, Professional Services, Finance, Securities Exchange Act of 1934, Program, Nature, Board, Share repurchase, EBC, Nasdaq, Company, Annual report, Private Securities Litigation Reform Act, Corus Bankshares, Forward-looking statement, Security (finance), Eastern Bank

Eastern expects to begin purchasing shares under the new repurchase program later this month after the Company purchases the shares remaining under its existing repurchase program.

Key Points: 
  • Eastern expects to begin purchasing shares under the new repurchase program later this month after the Company purchases the shares remaining under its existing repurchase program.
  • As previously announced, Eastern received regulatory non-objection in November 2021 for its inaugural share repurchase program, under which it was authorized to purchase up to 9,337,900 shares for up to $225 million over a 12-month period.
  • Eastern is not obligated to repurchase any particular number of shares under the program.
  • Eastern provides banking, investment and insurance products and services for consumers and businesses of all sizes, including through its Eastern Wealth Management division and its Eastern Insurance Group LLC subsidiary.